Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Mosior

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biology Direct|August 3, 2019
Massive metagenomic data analysis using abundance-based machine learningZachary N Harris, Eliza Dhungel, Matthew Mosior, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancerSharon L Freshour, Timothy H-P Chen, Bryan Fisk, et al.
Iscience|October 9, 2023
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancerSharon L Freshour, Timothy H-P Chen, Bryan Fisk, et al.
Arxiv|August 3, 2021
Bam-readcount - rapid generation of basepair-resolution sequence metricsAjay Khanna, David E Larson, Sridhar Nonavinkere Srivatsan, et al.
Cancer Genetics|March 6, 2026
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursorsFelicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, et al.
Blood|November 15, 2021
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphomaJeffrey P Ward, Melissa M Berrien-Elliott, Felicia Gomez, et al.
Blood Advances|July 26, 2023
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin LymphomaJennifer A Foltz, Brian T Hess, Veronika Bachanova, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Science Translational Medicine|February 23, 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biology Direct|August 3, 2019
Massive metagenomic data analysis using abundance-based machine learningZachary N Harris, Eliza Dhungel, Matthew Mosior, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancerSharon L Freshour, Timothy H-P Chen, Bryan Fisk, et al.
Iscience|October 9, 2023
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancerSharon L Freshour, Timothy H-P Chen, Bryan Fisk, et al.
Arxiv|August 3, 2021
Bam-readcount - rapid generation of basepair-resolution sequence metricsAjay Khanna, David E Larson, Sridhar Nonavinkere Srivatsan, et al.
Cancer Genetics|March 6, 2026
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursorsFelicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, et al.
Blood|November 15, 2021
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphomaJeffrey P Ward, Melissa M Berrien-Elliott, Felicia Gomez, et al.
Blood Advances|July 26, 2023
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin LymphomaJennifer A Foltz, Brian T Hess, Veronika Bachanova, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Science Translational Medicine|February 23, 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, et al.
Pageof 1